AI Compliance in Pharma: EU, US & UK Legislative Insights
Shirantha Samarappuli, PhD
20 Jun, 2025
“I want to thank your team for the valuable contribution and partnership during this project. It’s noteworthy to mention that the clinical assessment phase was passed the BSI assessment without any questions / additional information being asked. This is primarily the CER/CEP evaluation and risk assessment.
Thank you the entire Celegence Team for the timely delivery of quality work which is continue to be accepted by EU Notified Bodies.”
Other Related Articles
28 Jul, 2025
25 Jul, 2025
27 Jun, 2025
